4.5 Article

Cost-related medication non-adherence among US adults with diabetes

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 143, Issue -, Pages 24-33

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2018.06.016

Keywords

Medication adherence; Diabetes; Income; Insurance; Lifestyle

Funding

  1. Agency for Healthcare Research and Quality [1R01HS018542]
  2. NIH/NIDDK [1R01DK113295]

Ask authors/readers for more resources

Aims: To examine factors that affect cost-related medication non-adherence (CRN), defined as taking medication less than as prescribed because of cost, among adults with diabetes and to determine their relative contribution in explaining CRN. Methods: Behavioral Risk Factor Surveillance System data for 2013-2014 were used to identify individuals with diabetes and their CRN. We modeled CRN as a function of financial factors, regimen complexity, and other contextual factors including diabetes care, lifestyle, and health factors. Dominance analysis was performed to rank these factors by relative importance. Results: CRN among U. S. adults with diabetes was 16.5%. Respondents with annual income <$ 50,000 and without health insurance were more likely to report CRN, compared to those with income >=$ 50,000 and those with insurance, respectively. Insulin users had 1.24 times higher risk of CRN compared to those not on insulin. Contextual factors that significantly affected CRN included diabetes care factors, lifestyle factors, and comorbid depression, arthritis, and COPD/asthma. Dominance analysis showed health insurance was the most important factor for respondents < 65 and depression was the most important factor for respondents > 65. Conclusions: In addition to traditional risk factors of CRN, compliance with annual recommendations for diabetes and healthy lifestyle were associated with lower CRN. Policies and social supports that address these contextual factors may help improve CRN. (C) 2018 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available